| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-05 |